Kevin Barry is a Senior Principal Scientist at Novartis, specializing in Global Discovery Chemistry with expertise in analytical chemistry and separation sciences. With over 20 years of experience, they have developed chromatographic and spectroscopic methods for the analysis and purification of small molecules, significantly contributing to the discovery of early-stage candidates. Prior roles include positions at Pfizer Global Research and Development and Biogen, where Kevin led teams in various capacities related to medicinal chemistry. They hold a degree from the University of Massachusetts, Amherst.
This person is not in any teams
This person is not in any offices